July 30, 2015 | The Israeli company Eximo Medical announced that it completed Series A funding round of $1.6 million. The round was led by Accelmed together with the Alfred Mann Institute at the Technion, the Technion R&D Foundation and a private investor. Eximo, which is based in Rehovot, is the developer of a hybrid patented catheter system called ‘Cathi’. Eximo Medical was founded in 2012.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments